Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 21 for:    stem cell kidney | ( Map: Canada )

Immune Response Following Treatment of Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01147536
Recruitment Status : Terminated (Sponsor's business decision)
First Posted : June 22, 2010
Last Update Posted : April 10, 2014
Sponsor:
Information provided by (Responsible Party):
Agenus Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2012
Actual Study Completion Date : June 2012
Certification/Extension First Submitted : January 14, 2014